Viridian Therapeutics Inc (VRDN) Options

VRDN more upside possible

Touched 20s today. Maybe it will stay above 20 tomorrow

LOW 20'S BY WEEKEND IMO !!!
GOOD LUCK

Good news. I don't think that this is merely a one-day runner.

BTIG RESEARCH ADJUST PRICE TARGET TO 56 FROM 46; STRONG BUY !!

Over 15 and having a good day today

VRDN under $15

I put into it a lot of $
423 shares!

It just doesn't want to move above $18
Yet, it's not diving much either.
What do you think at this point? Sell temporarily and by later low?
My average is too high @17.76 !

Viridian Therapeutics, Inc., formerly Miragen Therapeutics, Inc., is a biotechnology company. The Company is engaged in developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications. Its lead candidate, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody (mAb) that is under development for thyroid eye disease (TED). The Company's TED pipeline also includes VRDN-002 and VRDN-003. Its other programs include VRDN-004, which is under development for undisclosed rare orphan disease, and VRDN-005, which is under development for tick-borne disease (TBD). The Company also out licenses its programs.